sglt2 and glp 1 Recommendations for SGLT2i versus GLP-1 RA on the basis of kidney SGLT-2 inhibitors and GLP-1 receptor
Description
Pairing A.G.E
This article reviews the clinical evidence, mechanisms, safety profile, and how genetic and biomarker assessments may inform personalized decisions
GLP-1 medication availability has improved significantly since 2023 shortages, opening new treatment pathways
GLP-1 medications have transformed weight management for millions of Americans, with adoption rates accelerating across all demographics
An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications that do not appear on drug labels.
Future looks bright, healthy & lean!
